Clinical Trials Logo

Migraine Headache clinical trials

View clinical trials related to Migraine Headache.

Filter by:

NCT ID: NCT00530517 Completed - Migraine Headache Clinical Trials

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

Start date: September 2007
Phase: Phase 2
Study type: Interventional

Intraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment. Study participation will last one month and include 2 doctor visits and 2-4 phone calls.

NCT ID: NCT00460005 Completed - Migraine Headache Clinical Trials

Clinical Study Of Migraine Evolution

Start date: January 2006
Phase: Phase 4
Study type: Observational

Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.

NCT ID: NCT00422812 Completed - Migraine Headache Clinical Trials

Staccato Prochlorperazine in Migraine (Out Patient)

Start date: April 2006
Phase: Phase 2
Study type: Interventional

Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches. In October 2005, we completed a 75 patient, multi-center, double-blind placebo-controlled Phase 2A clinical trial in patients suffering from moderate to severe acute migraine headaches. This Phase 2B clinical trial of Staccato Prochlorperazine has been initiated to assess the efficacy and safety in outpatients with migraine headache with or without aura.

NCT ID: NCT00287781 Completed - Migraine Headache Clinical Trials

A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache

Start date: January 2002
Phase: N/A
Study type: Interventional

Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. It would also spare the patient narcotics with their attendant side effects. Because of the potential for placebo effect a placebo control is necessary in this study.

NCT ID: NCT00203255 Completed - Migraine Headache Clinical Trials

Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache

Start date: May 2003
Phase: N/A
Study type: Interventional

The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide insight into the menstrual cycle and menstrually-related headaches in women. With this information, we may be able to change current treatment methods or even develop new methods in order to advance current approaches in the treatment of menstrual migraine.

NCT ID: NCT00172094 Completed - Migraine Headache Clinical Trials

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Start date: December 31, 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.

NCT ID: NCT00055484 Completed - Migraine Headache Clinical Trials

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

Start date: March 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.